Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases.

Benz, Dominik C; Gräni, Christoph; Antiochos, Panagiotis; Heydari, Bobak; Gissler, Mark Colin; Ge, Yin; Cuddy, Sarah A M; Dorbala, Sharmila; Kwong, Raymond Y (2023). Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases. European heart journal, 44(45), pp. 4738-4747. Oxford University Press 10.1093/eurheartj/ehad510

Text ehad510.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Author holds Copyright Download (790kB)

Cardiac magnetic resonance offers multiple facets in the diagnosis, risk stratification, and management of patients with myocardial diseases. Particularly, its feature to precisely monitor disease activity lends itself to quantify response to novel therapeutics. This review critically appraises the value of cardiac magnetic resonance imaging biomarkers as surrogate endpoints for prospective clinical trials. The primary focus is to comprehensively outline the value of established cardiac magnetic resonance parameters in myocardial diseases. These include heart failure, cardiac amyloidosis, iron overload cardiomyopathy, hypertrophic cardiomyopathy, cardio-oncology, and inflammatory cardiomyopathies like myocarditis and sarcoidosis.

Interest & Impact

Downloads

1 since deposited on 14 Sep 2023
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item